RNPCX
Price
$70.81
Change
-$0.20 (-0.28%)
Updated
Sep 17 closing price
Net Assets
162.63B
RNPEX
Price
$71.95
Change
-$0.20 (-0.28%)
Updated
Sep 17 closing price
Net Assets
162.63B
Interact to see
Advertisement

RNPCX vs RNPEX

Header iconRNPCX vs RNPEX Comparison
Open Charts RNPCX vs RNPEXBanner chart's image
American Funds New Perspective R3
Price$70.81
Change-$0.20 (-0.28%)
VolumeN/A
Net Assets162.63B
American Funds New Perspective R4
Price$71.95
Change-$0.20 (-0.28%)
VolumeN/A
Net Assets162.63B
RNPCX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNPCX vs. RNPEX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPCX is a Buy and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX (163B) and RNPEX (163B) have equal amount of cash in the bank . RNPEX pays higher dividends than RNPCX: RNPEX (0.48) vs RNPCX (0.22). RNPCX was incepted earlier than RNPEX: RNPCX (23 years) vs RNPEX (23 years). RNPCX (1.06) is less costly to investors than RNPEX (0.76). RNPCX (24.00) and RNPEX (24.00) have comparable annual turnover. RNPCX (250) and RNPEX (250) have matching initial minimum investment requirements. RNPEX (14.70) and RNPCX (14.27) have marching annual gain over last year. RNPEX (38.75) and RNPCX (36.91) have equivalent 5 years return.
RNPCXRNPEXRNPCX / RNPEX
Total Expense Ratio1.060.76139%
Annual Report Gross Expense Ratio1.060.76139%
Fund Existence23 years23 years-
Gain YTD17.87918.12599%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets163B163B100%
Annual Yield % from dividends0.220.4846%
Returns for 1 year14.2714.7097%
Returns for 3 years50.2751.3698%
Returns for 5 years36.9138.7595%
Returns for 10 years98.22101.1797%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCNI1.600.03
+1.59%
Scinai Immunotherapeutics Ltd.
PEN256.29-6.67
-2.54%
Penumbra
MRVI2.81-0.08
-2.77%
Maravai LifeSciences Holdings
RZLV7.11-0.24
-3.27%
Rezolve AI PLC
CRVO7.79-0.32
-3.95%
CervoMed